| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.866188 |
| 003 | CaOODSP |
| 005 | 20221107162003 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 181218t20192019onc o f000 0 eng d |
| 020 | |a9780660290362 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH169-10/2019E-PDF |
| 245 | 00|aQuestions and answers : |bprescription opioids ‐ sticker and handout requirements for pharmacists and practitioners. |
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019. |
| 264 | 4|c©2019 |
| 300 | |a1 online resource (12 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Foire aux questions : opioïdes sur ordonnance ‐ exigences relatives à l'autocollant et à la fiche de renseignements pour les pharmaciens et les praticiens. |
| 500 | |aCover title. |
| 500 | |a"Date: 2019/02/07." |
| 500 | |a"Publication date: February 2019." |
| 500 | |a"Pub.: 180653." |
| 500 | |aIssued also in HTML format. |
| 504 | |aIncludes bibliographical references. |
| 520 | |a"This document provides guidance on the regulatory requirements specified in Part C, Division 1 of the Food and Drug Regulations regarding prescription labelling requirements for opioid drugs identified in Part A of the List of Opioids"--Introduction, page 6. |
| 692 | 07|2gccst|aPrescription drugs |
| 692 | 07|2gccst|aDrug labelling |
| 710 | 1 |aCanada. |bHealth Canada. |
| 775 | 08|tFoire aux questions : |w(CaOODSP)9.866190 |
| 795 | |tQuestions and answers |w(CaOODSP)9.854773 |
| 856 | 40|qPDF|s261 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H169-10-2019-eng.pdf |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/policies/opioids-questions-answers.html |